Aer Therapeutics logo

Aer Therapeutics Funding & Investors

Aer Therapeutics is a clinical-stage biopharmaceutical company that develops an approach to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with significant unmet needs, such as COPD, cystic fibrosis, and asthma.

aertherapeutics.com

Total Amount Raised: $36,000,000

Aer Therapeutics Funding Rounds

  • Series A

    $36,000,000

    Series A Investors

    OrbiMed Advisors
    Canaan
    Hatteras Venture Partners
Funding info provided by Diffbot.